CALGB/Alliance 40603: Long-term outcomes (LTOs) after neoadjuvant chemotherapy (NACT) (+/- carboplatin (Cb) and bevacizumab (Bev)) in triple-negative breast cancer (TNBC)
- Citation:
- J Clin Oncol vol 37 (15 suppl) 591
- Meeting Instance:
- ASCO 2019
- Year:
- 2019
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Pharmas:
- Genentech
- Grants:
- U10CA180821, U10CA180882; U10CA180888 (SWOG);
- Corr. Author:
- Authors:
- William M Sikov Mei-Yin C Polley Erin L Twohy Charles M Perou Baljit Singh Donald A Berry Sara M Tolaney George Somlo Elisa R Port Cynthia Ma Charles Kuzma Eleftherios Mamounas Mehra Golshan Jennifer R Bellon Deborah Collyar Olwen M Hahn Clifford A Hudis Eric P Winer Ann Partridge Lisa A Carey
- Networks:
- CA043, LAPS-CT018, LAPS-IL057, LAPS-MA036, LAPS-MO011, LAPS-NC007, LAPS-NY016, NY021, RI005, SCOR
- Study
- CALGB-40603
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: